XCHG Limited XCH
3.23
0.07
2.22%
as of 25 Sep
- Market cap
- $9.2M
- P/E
- —
Follow XCH
| Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|
P/S ratio |
0.00 | 0.00 | 0.00 |
P/FCF ratio |
0.00 | 0.00 | 0.00 |
P/Operating CF |
(1,064.14) | (293.51) | (163.38) |
P/B ratio |
0.00 | 0.00 | 36.41 |
Price to Tangible BV |
0.00 | 0.00 | 36.43 |
EV/Sales |
0.00 | 0.00 | 0.00 |
EV/EBITDA |
0.00 | 0.00 | 0.00 |
EV/Operating CF |
0.00 | 0.00 | 0.00 |
EV/FCF |
0.00 | 0.00 | 0.00 |
Quick Ratio |
0.97 | 1.54 | 1.00 |
Current Ratio |
1.29 | 2.08 | 1.58 |
Net Debt/EBITDA |
(0.38) | 1.52 | 0.23 |
Debt/Assets |
44.13% | 15.42% | 15.00% |
Debt/Equity |
(0.60) | 0.30 | 0.36 |
Asset Turnover |
0.00 | 0.86 | 0.50 |
Operating CF/Net income |
0.53 | 0.55 | 0.23 |
Capex/Depreciation |
(2.59) | (2.63) | (2.46) |
Interest Coverage |
0.00 | 0.00 | 0.00 |
| 0.00% | 1,036.74% | (137.21%) | |
| 0.00% | (26.71%) | (65.13%) | |
ROIC |
0.00% | (65.12%) | (196.76%) |
Return on Tangible Assets |
(109.04%) | (44.89%) | (209.08%) |
Average Days of Receivables |
134.27 | 116.39 | 138.48 |
Research and Development Expense of Revenue |
10.54% | 28.81% | 28.17% |
Selling, General and Administrative Expense of Revenue |
53.12% | 50.07% | 148.46% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
19.36% | 16.66% | 83.43% |
Graham Net Nets |
(0.01) | (0.02) | 0.02 |
Graham Number |
0.00 | 0.00 | 0.00 |
Free Cash Flow Yield |
0.00% | 0.00% | 0.00% |
Revenue per Share |
1.08 | 26.23 | 7.18 |
Operating CF per Share |
(0.16) | (4.48) | (2.15) |
Capex per Share |
(0.01) | (0.38) | (0.19) |
Free Cash Flow per Share |
(0.17) | (4.86) | (2.35) |
Cash per Share |
0.44 | 16.64 | 3.98 |
Shareholders Equity per Share |
(0.84) | 18.34 | 5.11 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 |
Book value per Share |
(0.84) | 18.34 | 5.11 |
Free Cash Flow |
(6.10) | (7.82) | (8.20) |
Working Capital |
9.02 | 28.22 | 13.57 |
Capital Expenditures |
(0.53) | (0.61) | (0.68) |
Net Current Asset Value |
(31.25) | 26.78 | 12.31 |
EV/EBIT |
0.00 | 0.00 | 0.00 |
Capex to Sales |
0.01 | 0.01 | 0.03 |
Net Profit Margin |
(27.16%) | (31.05%) | (129.49%) |
Price to Operating Income |
0.00 | 0.00 | 0.00 |
| Other line items | |||
Depreciation/Fixed assets |
0.35 | 0.24 | 0.14 |
Cash ROIC |
(164.82%) | (12.55%) | (24.88%) |
Accounts Receivable Turnover |
0.00 | 3.06 | 2.18 |
Accounts Payable Turnover |
0.00 | 3.13 | 1.88 |
Inventory Turnover |
0.00 | 2.93 | 1.58 |
Average Days of Payables |
100.24 | 133.38 | 181.84 |
Days of Inventory on Hand |
116.04 | 133.65 | 254.98 |
Average Receivables |
— | 13.81 | 11.49 |
Average Payables |
— | 6.71 | 7.20 |
Average Inventory |
— | 7.17 | 8.56 |
Average Assets |
— | 49.05 | 49.90 |
Average Common Equity |
— | (1.26) | 23.69 |
Columns are period end dates · fundamentals updated 23 Sep 2026